Beyond religion
The Peptide Contradiction
Demanding decades of safety data, then injecting something with three human studies.
The point in one sentence
The same people who say vaccines do not have enough long term safety data are injecting compounds with three human studies total, bought from unregulated suppliers.
Set it up carefully
Do not open with the contradiction. Ask what they take and why. Let them explain the reasoning. Then ask what evidence convinced them, in the same tone you would use about anything else.
The same standard, applied to both
What exists behind each, side by side.
| MMR vaccine | BPC-157 | |
|---|---|---|
| Human studies | Millions of children across multiple national cohorts | Three pilot studies |
| Regulatory approval | FDA, EMA, and equivalents worldwide | None, anywhere |
| Manufacturing oversight | Batch tested, inspected facilities | Often "research chemical only" suppliers |
| Ongoing safety monitoring | VAERS plus active surveillance systems | None |
| Verified purity | Confirmed per batch | Measured as low as 7.7% in tested samples |
Sources: 2025 review in Current Reviews in Musculoskeletal Medicine; JMIR 2024 purity study; USADA
BPC-157: what actually exists
- A 2025 review found exactly three pilot human studies. Everything else is animal data.
- Its own conclusion: "until well designed clinical trials are conducted, BPC-157 should be considered investigational." The review
- It is banned in sport under WADA's category for substances not approved for human use anywhere. USADA
What is actually in the vial
A 2024 study bought semaglutide from online sellers without a prescription and tested it:
- Measured purity: 7.7 to 14.4 percent, against a claimed 99 percent.
- Bacterial endotoxin contamination in every sample tested.
- The paper's own term: "probable substandard and falsified." The study
Approved GLP-1 drugs work. The problem is the gray market supply chain, not the molecule.
Their underlying instinct is not crazy. Purdue lied about OxyContin. The revolving door between the FDA and industry is real. Direct to consumer pharmaceutical advertising is allowed in only two countries on earth.
The question to ask
What evidence would you need before you would take something? Because whatever that standard is, I want to apply it to both of these.
Usually what surfaces is that the standard is not about evidence at all. It is about who is telling you. That is a trust question, not an evidence question, and naming it accurately is more useful than winning on data.